MetaADEDB 2.0 @ LMMD
17 alpha-Hydroxyprogesterone Caproate
(DOMWKUIIPQCAJU-LJHIYBGHSA-N)
Structure
SMILES
CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C)C(=O)C
Type(s)
Approved; Investigational
Molecular Formula:
C27H40O4
Molecular Weight:
428.604
Log P:
5.9696
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
60.44
CAS Number(s):
630-56-8
Synonym(s)
1.
17 alpha-Hydroxyprogesterone Caproate
2.
17 alpha-Oxyprogesterone Capronate
3.
17-Hydroxyprogesterone Capronate
4.
17-alpha-Hydroxy-Progesterone Caproate
5.
Delalutin
6.
Hydroxyprogesterone Caproate
7.
Hydroxyprogesterone Hexanoate
8.
Makena
9.
Neolutin
10.
Oxyprogesterone Caproate
11.
Prolutin Depot
12.
Proluton Depot
13.
17 Hydroxyprogesterone Capronate
14.
17 alpha Hydroxy Progesterone Caproate
15.
17 alpha Hydroxyprogesterone Caproate
16.
17 alpha Oxyprogesterone Capronate
17.
Caproate, 17-alpha-Hydroxy-Progesterone
External Link(s)
MeSHD000077713
PubChem Compound169870
BindingDB70293
ChEBI5812
CHEMBLCHEMBL1200848
DrugBankDB06789
DrugCentral4189
KEGGcpd:C08148
dr:D00949
Therapeutic Target DatabaseD00AEQ
ZINC4083606
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Injection site painFAERS: 1090US FAERS
2Injection site pruritusFAERS: 846US FAERS
3Uterine contractions during pregnancyFAERS: 411US FAERS
4Injection site massFAERS: 349US FAERS
5StillbirthFAERS: 334US FAERS
6Inappropriate schedule of product administrationFAERS: 277US FAERS
7Injection site erythemaFAERS: 277US FAERS
8HeadacheFAERS: 261US FAERS
9PruritusFAERS: 260US FAERS
10NauseaFAERS: 257US FAERS
11Product dose omissionFAERS: 187US FAERS
12DizzinessFAERS: 178US FAERS
13PainFAERS: 156US FAERS
14FatigueFAERS: 139US FAERS
15Back PainFAERS: 135US FAERS
16Injection site bruisingFAERS: 128US FAERS
17Injection site noduleFAERS: 126US FAERS
18VomitingFAERS: 125US FAERS
19Injection site warmthFAERS: 112US FAERS
20Peripheral swellingFAERS: 109US FAERS
21Medication ErrorFAERS: 108US FAERS
22Injection Site ReactionFAERS: 96US FAERS
23HypersensitivityFAERS: 95
Canada Vigilance: 1
Canada Vigilance
US FAERS
24UrticariaFAERS: 91US FAERS
25Product administration errorFAERS: 86US FAERS
26Abdominal PainFAERS: 76US FAERS
27Shortened cervixFAERS: 72US FAERS
28AnxietyFAERS: 71US FAERS
29Pre-EclampsiaFAERS: 70US FAERS
30Product administered at inappropriate siteFAERS: 66US FAERS
31Injection site urticariaFAERS: 65US FAERS
32Maternal exposure during pregnancyFAERS: 63US FAERS
33ErythemaFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
34MalaiseFAERS: 60US FAERS
35ArthralgiaFAERS: 57US FAERS
36Burning sensationFAERS: 57US FAERS
37SwellingFAERS: 56US FAERS
38Inappropriate schedule of drug administrationFAERS: 55US FAERS
39Urinary tract infectionFAERS: 52US FAERS
40Abdominal discomfortFAERS: 51US FAERS
41Gestational DiabetesFAERS: 44US FAERS
42Vaginal DischargeFAERS: 42US FAERS
43Breech PresentationFAERS: 39US FAERS
44SomnolenceFAERS: 39US FAERS
45Drug dose omissionFAERS: 38US FAERS
46AstheniaFAERS: 35US FAERS
47Chest discomfortFAERS: 35US FAERS
48PalpitationsFAERS: 35US FAERS
49Limb discomfortFAERS: 34US FAERS
50Emotional disorderFAERS: 32US FAERS
51Mood swingsFAERS: 32US FAERS
52Feeling abnormalFAERS: 29US FAERS
53Adverse eventFAERS: 28US FAERS
54Drug administered at inappropriate siteFAERS: 28US FAERS
55Injection site irritationFAERS: 28US FAERS
56SyncopeFAERS: 28US FAERS
57Chest PainFAERS: 26US FAERS
58Pelvic PainFAERS: 25US FAERS
59Blood glucose increasedFAERS: 24US FAERS
60DehydrationFAERS: 24US FAERS
61ConstipationFAERS: 23US FAERS
62Throat irritationFAERS: 23US FAERS
63NasopharyngitisFAERS: 22US FAERS
64Depressed moodFAERS: 21US FAERS
65Injection site discomfortFAERS: 21US FAERS
66MyalgiaFAERS: 21US FAERS
67DyspepsiaFAERS: 20US FAERS
68Maternal exposure timing unspecifiedFAERS: 19US FAERS
69CryingFAERS: 18US FAERS
70DiscomfortFAERS: 18US FAERS
71DysgeusiaFAERS: 18US FAERS
72Vulvovaginal discomfortFAERS: 18US FAERS
73AsthmaFAERS: 17US FAERS
74EpistaxisFAERS: 17US FAERS
75Injection site extravasationFAERS: 17US FAERS
76OligohydramniosFAERS: 17US FAERS
77PresyncopeFAERS: 17US FAERS
78InfectionFAERS: 16US FAERS
79Injection site hypersensitivityFAERS: 16US FAERS
80Injection site inflammationFAERS: 16US FAERS
81SciaticaFAERS: 15US FAERS
82CellulitisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
83ChillsFAERS: 14US FAERS
84NoduleFAERS: 13US FAERS
85OverdoseFAERS: 13US FAERS
86Pelvic discomfortFAERS: 13US FAERS
87AngerFAERS: 12US FAERS
88Cholestasis of pregnancyFAERS: 12US FAERS
89Injection site infectionFAERS: 12US FAERS
90Blood glucose decreasedFAERS: 11US FAERS
91Muscle tightnessFAERS: 11US FAERS
92Musculoskeletal stiffnessFAERS: 11US FAERS
93NephrolithiasisFAERS: 11US FAERS
94Accidental overdoseFAERS: 10US FAERS
95AlopeciaFAERS: 10US FAERS
96Injection site movement impairmentFAERS: 10US FAERS
97Neonatal respiratory distressFAERS: 10US FAERS
98Vulvovaginal painFAERS: 10US FAERS
99Bacterial VaginosisFAERS: 9US FAERS
100Incorrect route of product administrationFAERS: 9US FAERS
101InfluenzaFAERS: 9US FAERS
102Joint swellingFAERS: 9US FAERS
103LethargyFAERS: 9US FAERS
104Lip swellingFAERS: 9US FAERS
105Musculoskeletal PainFAERS: 9US FAERS
106TremorFAERS: 9US FAERS
107Drug administration errorFAERS: 8US FAERS
108HypotensionFAERS: 8US FAERS
109Incorrect dose administeredFAERS: 8US FAERS
110Injection site scabFAERS: 8US FAERS
111Trisomy 21FAERS: 8US FAERS
112AcneFAERS: 7US FAERS
113Blood glucose abnormalFAERS: 7US FAERS
114Fibronectin increasedFAERS: 7US FAERS
115FlushingFAERS: 7US FAERS
116Incorrect route of drug administrationFAERS: 7US FAERS
117Injection site vesiclesFAERS: 7US FAERS
118Musculoskeletal discomfortFAERS: 7US FAERS
119Product prescribing issueFAERS: 7US FAERS
120Therapy cessationFAERS: 7US FAERS
121Unevaluable eventFAERS: 7US FAERS
122Uterine RuptureFAERS: 7US FAERS
123Uterine spasmFAERS: 7US FAERS
124Amniotic fluid volume decreasedFAERS: 6US FAERS
125Blood iron decreasedFAERS: 6US FAERS
126Cervix enlargementFAERS: 6US FAERS
127Cold sweatFAERS: 6US FAERS
128HungerFAERS: 6US FAERS
129PneumoniaFAERS: 6US FAERS
130Poor feeding infantFAERS: 6US FAERS
131ChromaturiaFAERS: 5US FAERS
132CystitisFAERS: 5US FAERS
133FlatulenceFAERS: 5US FAERS
134Incorrect dose administered by deviceFAERS: 5US FAERS
135Injection site abscessFAERS: 5US FAERS
136Injection site scarFAERS: 5US FAERS
137Placenta AccretaFAERS: 5US FAERS
138SepsisFAERS: 5US FAERS
139Umbilical cord vascular disorderFAERS: 5US FAERS
140VertigoFAERS: 5US FAERS
141Visual ImpairmentFAERS: 5US FAERS
142ABO incompatibilityFAERS: 4US FAERS
143AbasiaFAERS: 4US FAERS
144Accidental exposure to productFAERS: 4US FAERS
145Bipolar DisorderFAERS: 4US FAERS
146Carpal Tunnel SyndromeFAERS: 4US FAERS
147Deep Vein ThrombosisFAERS: 4US FAERS
148DiplopiaFAERS: 4US FAERS
149Drug exposure during pregnancyFAERS: 4US FAERS
150Dry skinFAERS: 4US FAERS
151DysuriaFAERS: 4US FAERS
152Low birth weight babyFAERS: 4US FAERS
153MicrocephalyFAERS: 4US FAERS
154Neck PainFAERS: 4US FAERS
155NervousnessFAERS: 4US FAERS
156PallorFAERS: 4US FAERS
157Pericardial effusionFAERS: 4US FAERS
158Pulmonary EmbolismFAERS: 4US FAERS
159Rash erythematousFAERS: 4US FAERS
160Selective eating disorderFAERS: 4US FAERS
161Single umbilical arteryFAERS: 4US FAERS
162TachycardiaFAERS: 4US FAERS
163ThrombosisFAERS: 417139407CTD
US FAERS
164TinnitusFAERS: 4US FAERS
165Weight decreasedFAERS: 4US FAERS
166Bone painFAERS: 3US FAERS
167BronchiolitisFAERS: 3US FAERS
168Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
169Cleft PalateFAERS: 3US FAERS
170Congenital heart valve disorderFAERS: 3US FAERS
171Diabetes mellitus inadequate controlFAERS: 3US FAERS
172Drug ineffectiveFAERS: 3US FAERS
173Emotional distressFAERS: 3US FAERS
174Eye painFAERS: 3US FAERS
175Feeling ColdFAERS: 3US FAERS
176HELLP SyndromeFAERS: 3US FAERS
177Immature respiratory systemFAERS: 3US FAERS
178Incorrect drug administration rateFAERS: 3US FAERS
179IndurationFAERS: 3US FAERS
180Injection site cellulitisFAERS: 3US FAERS
181Joint stiffnessFAERS: 3US FAERS
182Lack of injection site rotationFAERS: 3US FAERS
183LaryngomalaciaFAERS: 3US FAERS
184Ligament painFAERS: 3US FAERS
185Meconium Aspiration SyndromeFAERS: 3US FAERS
186Muscle strainFAERS: 3US FAERS
187Musculoskeletal chest painFAERS: 3US FAERS
188Neonatal aspirationFAERS: 3US FAERS
189Obstetric procedure complicationFAERS: 3US FAERS
190Oropharyngeal discomfortFAERS: 3US FAERS
191Oropharyngeal painFAERS: 3US FAERS
192Patent ductus arteriosusFAERS: 3US FAERS
193PolyhydramniosFAERS: 3US FAERS
194Product prescribing errorFAERS: 3US FAERS
195Progesterone increasedFAERS: 3US FAERS
196Restless Legs SyndromeFAERS: 3US FAERS
197RestlessnessFAERS: 3US FAERS
198Skin PapillomaFAERS: 3US FAERS
199Skin reactionFAERS: 3US FAERS
200StressFAERS: 3US FAERS
201TalipesFAERS: 3US FAERS
202Vulvovaginal pruritusFAERS: 3US FAERS
203Weight decrease neonatalFAERS: 3US FAERS
204WheezingFAERS: 3US FAERS
205Wrong technique in drug usage processFAERS: 3US FAERS
206jaundiceFAERS: 3US FAERS
207Abdominal rigidityFAERS: 2US FAERS
208Alcohol interactionFAERS: 2US FAERS
209Amniotic fluid volume increasedFAERS: 2US FAERS
210Bed restFAERS: 2US FAERS
211BedriddenFAERS: 2US FAERS
212Bladder painFAERS: 2US FAERS
213Blood glucose fluctuationFAERS: 2US FAERS
214Blood urine presentFAERS: 2US FAERS
215Body temperature fluctuationFAERS: 2US FAERS
216Breast tendernessFAERS: 2US FAERS
217BronchitisFAERS: 2US FAERS
218Cardiac ArrestFAERS: 2US FAERS
219CarditisFAERS: 2US FAERS
220CholestasisFAERS: 2US FAERS
221ChorioamnionitisFAERS: 2US FAERS
222Congenital hearing disorderFAERS: 2US FAERS
223DermatitisFAERS: 2US FAERS
224Device use issueFAERS: 2US FAERS
225DextrocardiaFAERS: 2US FAERS
226Diabetes MellitusFAERS: 2US FAERS
227Drug prescribing errorFAERS: 2US FAERS
228EczemaFAERS: 2US FAERS
229EpilepsyFAERS: 2US FAERS
230Eye irritationFAERS: 2US FAERS
231Facial PainFAERS: 2US FAERS
232FibromyalgiaFAERS: 2US FAERS
233FormicationFAERS: 2US FAERS
234Gait inabilityFAERS: 2US FAERS
235GastritisFAERS: 2US FAERS
236Genital painFAERS: 2US FAERS
237Head deformityFAERS: 2US FAERS
238Hormone level abnormalFAERS: 2US FAERS
239Hyperemesis GravidarumFAERS: 2US FAERS
240HypersomniaFAERS: 2US FAERS
241HypokinesiaFAERS: 2US FAERS
242HypophagiaFAERS: 2US FAERS
243Impaired work abilityFAERS: 2US FAERS
244ImpatienceFAERS: 2US FAERS
245Injection site dischargeFAERS: 2US FAERS
246Injection site drynessFAERS: 2US FAERS
247Injury associated with deviceFAERS: 2US FAERS
248Invasive Ductal Breast CarcinomaFAERS: 2US FAERS
249Joint InstabilityFAERS: 2US FAERS
250LazinessFAERS: 2US FAERS
251Loss of personal independence in daily activitiesFAERS: 2US FAERS
252MastitisFAERS: 2US FAERS
253Maternal exposure during deliveryFAERS: 2US FAERS
254Meconium plug syndromeFAERS: 2US FAERS
255Medical device painFAERS: 2US FAERS
256Migraine with AuraFAERS: 2US FAERS
257MonoplegiaFAERS: 2US FAERS
258Mouth swellingFAERS: 2US FAERS
259Neonatal infectionFAERS: 2US FAERS
260Neonatal respiratory failureFAERS: 2US FAERS
261NeuralgiaFAERS: 2US FAERS
262Oxygen supplementationFAERS: 2US FAERS
263PetechiaeFAERS: 2US FAERS
264Pharyngeal swellingFAERS: 2US FAERS
265Placental InsufficiencyFAERS: 2US FAERS
266Poor peripheral circulationFAERS: 2US FAERS
267PregnancyFAERS: 2US FAERS
268Product quality issueFAERS: 2US FAERS
269Product storage errorFAERS: 2US FAERS
270Pulmonary interstitial emphysema syndromeFAERS: 2US FAERS
271PyelocaliectasisFAERS: 2US FAERS
272Renal painFAERS: 2US FAERS
273RetchingFAERS: 2US FAERS
274ScabFAERS: 2US FAERS
275Shoulder DystociaFAERS: 2US FAERS
276SinusitisFAERS: 2US FAERS
277Skin IndurationFAERS: 2US FAERS
278Skin irritationFAERS: 2US FAERS
279Skin lesionFAERS: 2US FAERS
280SluggishnessFAERS: 2US FAERS
281Spina BifidaFAERS: 2US FAERS
282StridorFAERS: 2US FAERS
283Therapy changeFAERS: 2US FAERS
284ThirstFAERS: 2US FAERS
285Varicose veins vaginalFAERS: 2US FAERS
286Vitreous floatersFAERS: 2US FAERS
287Vulvovaginal burning sensationFAERS: 2US FAERS
288Vulvovaginal swellingFAERS: 2US FAERS
289Wrong technique in product usage processFAERS: 2US FAERS
290treatment failureFAERS: 2US FAERS
291Abdominal massFAERS: 1US FAERS
292Abdominal tendernessFAERS: 1US FAERS
293Administration site indentationFAERS: 1US FAERS
294Administration site movement impairmentFAERS: 1US FAERS
295Adnexa uteri painFAERS: 1US FAERS
296Adrenal insufficiency neonatalFAERS: 1US FAERS
297AgitationFAERS: 1US FAERS
298Amino acid level increasedFAERS: 1US FAERS
299Ankle FractureFAERS: 1US FAERS
300Apparent life threatening eventFAERS: 1US FAERS
301ArthropathyFAERS: 1US FAERS
302Arthropod biteFAERS: 1US FAERS
303Atrial FibrillationFAERS: 1US FAERS
304Atrioventricular Septal DefectFAERS: 1US FAERS
305AuraFAERS: 1US FAERS
306Autoimmune progesterone dermatitisFAERS: 1US FAERS
307Bacterial disease carrierFAERS: 1US FAERS
308Biliary ColicFAERS: 1US FAERS
309Blood HIV RNA increasedFAERS: 1US FAERS
310Blood bilirubin abnormalFAERS: 1US FAERS
311Blood potassium decreasedFAERS: 1US FAERS
312Blood pressure fluctuationFAERS: 1US FAERS
313Blood pressure inadequately controlledFAERS: 1US FAERS
314Blood sodium decreasedFAERS: 1US FAERS
315Blood testosterone increasedFAERS: 1US FAERS
316Bowel movement irregularityFAERS: 1US FAERS
317BradycardiaFAERS: 1US FAERS
318Breast engorgementFAERS: 1US FAERS
319BursitisFAERS: 1US FAERS
320Cardiac FlutterFAERS: 1US FAERS
321Cardiac HypertrophyFAERS: 1US FAERS
322Cardiomyopathy neonatalFAERS: 1US FAERS
323CataractFAERS: 1US FAERS
324Chronic villitis of unknown etiologyFAERS: 1US FAERS
325Coagulation factor X level abnormalFAERS: 1US FAERS
326ColitisFAERS: 1US FAERS
327Complication of deliveryFAERS: 1US FAERS
328Congenital HydrocephalusFAERS: 1US FAERS
329Congenital cystic kidney diseaseFAERS: 1US FAERS
330Congenital cytomegalovirus infectionFAERS: 1US FAERS
331Congenital heart valve incompetenceFAERS: 1US FAERS
332CyanosisFAERS: 1US FAERS
333Dacryostenosis acquiredFAERS: 1US FAERS
334Device breakageFAERS: 1US FAERS
335Device malfunctionFAERS: 1US FAERS
336Device related infectionFAERS: 1US FAERS
337Diabetes mellitus managementFAERS: 1US FAERS
338Diabetic KetoacidosisFAERS: 1US FAERS
339DiaphragmalgiaFAERS: 1US FAERS
340Disease complicationFAERS: 1US FAERS
341Documented hypersensitivity to administered drugFAERS: 1US FAERS
342Drug dispensing errorFAERS: 1US FAERS
343Drug withdrawal syndromeFAERS: 1US FAERS
344DysarthriaFAERS: 1US FAERS
345DysphoniaFAERS: 1US FAERS
346Ear discomfortFAERS: 1US FAERS
347EclampsiaFAERS: 1US FAERS
348Economic problemFAERS: 1US FAERS
349EnuresisFAERS: 1US FAERS
350EructationFAERS: 1US FAERS
351Expired product administeredFAERS: 1US FAERS
352Exposure via skin contactFAERS: 1US FAERS
353Face presentationFAERS: 1US FAERS
354Failure to ThriveFAERS: 1US FAERS
355Feeding tube userFAERS: 1US FAERS
356Feeling jitteryFAERS: 1US FAERS
357Feeling of body temperature changeFAERS: 1US FAERS
358Flat affectFAERS: 1US FAERS
359Food PoisoningFAERS: 1US FAERS
360Frustration tolerance decreasedFAERS: 1US FAERS
361Full blood count increasedFAERS: 1US FAERS
362Gallbladder painFAERS: 1US FAERS
363Gastrointestinal viral infectionFAERS: 1US FAERS
364GastroschisisFAERS: 1US FAERS
365GlossitisFAERS: 1US FAERS
366GranulomaFAERS: 1US FAERS
367Head discomfortFAERS: 1US FAERS
368HerniaFAERS: 1US FAERS
369HidradenitisFAERS: 1US FAERS
370HordeolumFAERS: 1US FAERS
371HydrocephalusFAERS: 1US FAERS
372HydronephrosisFAERS: 1US FAERS
373HyperthyroidismFAERS: 1US FAERS
374HyperventilationFAERS: 1US FAERS
375HypospadiasFAERS: 1US FAERS
376HypothyroidismFAERS: 1US FAERS
377HysterectomyFAERS: 1US FAERS
378Imminent abortionFAERS: 1US FAERS
379Impaired driving abilityFAERS: 1US FAERS
380IncoherentFAERS: 1US FAERS
381Incorrect product administration durationFAERS: 1US FAERS
382Infantile vomitingFAERS: 1US FAERS
383InfertilityFAERS: 1US FAERS
384InflammationFAERS: 1US FAERS
385Injected limb mobility decreasedFAERS: 1US FAERS
386Injection site dermatitisFAERS: 1US FAERS
387Injection site indentationFAERS: 1US FAERS
388Injection site injuryFAERS: 1US FAERS
389Injection site nerve damageFAERS: 1US FAERS
390Injection site papuleFAERS: 1US FAERS
391Intellectual DisabilityFAERS: 1US FAERS
392Intercepted drug dispensing errorFAERS: 1US FAERS
393Invasive Lobular Breast CarcinomaFAERS: 1US FAERS
394Joint injuryFAERS: 1US FAERS
395Kell blood group positiveFAERS: 1US FAERS
396Left Ventricular HypertrophyFAERS: 1US FAERS
397Ligament ruptureFAERS: 1US FAERS
398Limb massFAERS: 1US FAERS
399Liquid product physical issueFAERS: 1US FAERS
400ListeriosisFAERS: 1US FAERS
401Local reactionFAERS: 1US FAERS
402Lung cystFAERS: 1US FAERS
403Lupus NephritisFAERS: 1US FAERS
404LymphadenopathyFAERS: 1US FAERS
405LymphangitisFAERS: 1US FAERS
406MacrocephalyFAERS: 1US FAERS
407MaculeFAERS: 1US FAERS
408MalnutritionFAERS: 1US FAERS
409Maternal exposure before pregnancyFAERS: 1US FAERS
410Mechanical urticariaFAERS: 1US FAERS
411MeningitisFAERS: 1US FAERS
412Menstrual discomfortFAERS: 1US FAERS
413MiliariaFAERS: 1US FAERS
414Milk AllergyFAERS: 1US FAERS
415Morning SicknessFAERS: 1US FAERS
416Multiple SclerosisFAERS: 1US FAERS
417Mycobacterium tuberculosis complex test positiveFAERS: 1US FAERS
418Myocardial InfarctionFAERS: 1US FAERS
419Needle issueFAERS: 1US FAERS
420Neonatal disorderFAERS: 1US FAERS
421Neonatal gastrointestinal disorderFAERS: 1US FAERS
422Neonatal hypotensionFAERS: 1US FAERS
423Neonatal pneumoniaFAERS: 1US FAERS
424Night sweatsFAERS: 1US FAERS
425Nipple painFAERS: 1US FAERS
426No adverse eventFAERS: 1US FAERS
427Nonspecific reactionFAERS: 1US FAERS
428Obstetric infectionFAERS: 1US FAERS
429OliguriaFAERS: 1US FAERS
430Oral pruritusFAERS: 1US FAERS
431Orgasmic sensation decreasedFAERS: 1US FAERS
432OsteopeniaFAERS: 1US FAERS
433Otitis MediaFAERS: 1US FAERS
434Panic DisorderFAERS: 1US FAERS
435Perineal injuryFAERS: 1US FAERS
436PharyngitisFAERS: 1US FAERS
437PhotophobiaFAERS: 1US FAERS
438PlagiocephalyFAERS: 1US FAERS
439PneumothoraxFAERS: 1US FAERS
440Poor weight gain neonatalFAERS: 1US FAERS
441Post procedural complicationFAERS: 1US FAERS
442Post procedural feverFAERS: 1US FAERS
443Postoperative ileusFAERS: 1US FAERS
444Premature baby deathFAERS: 1US FAERS
445Product depositFAERS: 1US FAERS
446Product dispensing issueFAERS: 1US FAERS
447Product distribution issueFAERS: 1US FAERS
448Product formulation issueFAERS: 1US FAERS
449Product intoleranceFAERS: 1US FAERS
450Product solubility abnormalFAERS: 1US FAERS
451Product substitution issueFAERS: 1US FAERS
452Product use issueFAERS: 1US FAERS
453Productive CoughFAERS: 1US FAERS
454Progesterone decreasedFAERS: 1US FAERS
455Protein urine presentFAERS: 1US FAERS
456PsoriasisFAERS: 1US FAERS
457Psychiatric symptomFAERS: 1US FAERS
458Pubic painFAERS: 1US FAERS
459Pulmonary malformationFAERS: 1US FAERS
460PyelonephritisFAERS: 1US FAERS
461Renal ColicFAERS: 1US FAERS
462Renal impairment neonatalFAERS: 1US FAERS
463Respiratory distressFAERS: 1US FAERS
464Respiratory tract congestionFAERS: 1US FAERS
465Retained products of conceptionFAERS: 1US FAERS
466Retinal Vein OcclusionFAERS: 1US FAERS
467RhabdomyomaFAERS: 1US FAERS
468RhinitisFAERS: 1US FAERS
469Rubber sensitivityFAERS: 1US FAERS
470Secretion dischargeFAERS: 1US FAERS
471Sinus headacheFAERS: 1US FAERS
472Skin indentationFAERS: 1US FAERS
473Small size placentaFAERS: 1US FAERS
474SneezingFAERS: 1US FAERS
475SomnambulismFAERS: 1US FAERS
476Staphylococcus test positiveFAERS: 1US FAERS
477Streptococcus test positiveFAERS: 1US FAERS
478Sudden infant death syndromeFAERS: 1US FAERS
479Temperature regulation disorderFAERS: 1US FAERS
480Tension HeadacheFAERS: 1US FAERS
481Thermal burnFAERS: 1US FAERS
482Throat clearingFAERS: 1US FAERS
483ThrombocytopeniaFAERS: 1US FAERS
484Tongue exfoliationFAERS: 1US FAERS
485Unresponsive to stimuliFAERS: 1US FAERS
486Urinary tract obstructionFAERS: 1US FAERS
487Uterine ProlapseFAERS: 1US FAERS
488Uterine cervical painFAERS: 1US FAERS
489Vaginal relaxationFAERS: 1US FAERS
490Vulvovaginal drynessFAERS: 1US FAERS
491Vulvovaginal mycotic infectionFAERS: 1US FAERS
492Wrong device usedFAERS: 1US FAERS
493Wrong drug administeredFAERS: 1US FAERS
494Wrong patient received medicationFAERS: 1US FAERS
495Wrong technique in device usage processFAERS: 1US FAERS
496inhibin BFAERS: 1US FAERS
497Carcinoma9208491CTD
498Endometrial Hyperplasia11695813CTD
499Endometrial Neoplasms

View details

CTD
500Fetal Resorption3816235CTD
501Liver Cirrhosis, Experimental1465320CTD
502Neoplasms, Experimental8068195CTD
503Neoplasms, Hormone-Dependent8500499CTD
504Obstetric Labor Complications16946206CTD
505Osteoporosis, Postmenopausal16373245CTD
506Ovarian Hyperstimulation Syndrome11719720
12960445
CTD
507Precancerous Conditions8082440CTD
508Pregnancy Complications19546757CTD
509Premature Birth

View details

CTD
510Uterine Cervical Incompetence19492920CTD
511Uterine hemorrhage17139407CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.